应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06996 德琪医药-B
未开盘 04-18 16:08:15
0.860
-0.030
-3.37%
最高
0.900
最低
0.840
成交量
18.20万
今开
0.880
昨收
0.890
日振幅
6.74%
总市值
5.80亿
流通市值
5.80亿
总股本
6.75亿
成交额
16.06万
换手率
0.03%
流通股本
6.75亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
德琪医药-B盘中异动 早盘快速下跌5.49%
自选股智能写手 · 04-17 10:20
德琪医药-B盘中异动 早盘快速下跌5.49%
德琪医药-B(06996)股价显著下跌10.989%,现价港币$0.81
阿斯达克财经 · 04-17 10:20
德琪医药-B(06996)股价显著下跌10.989%,现价港币$0.81
德琪医药-B盘中异动 大幅跳水5.15%报0.920港元
自选股智能写手 · 04-12
德琪医药-B盘中异动 大幅跳水5.15%报0.920港元
德琪医药-B盘中异动 下午盘股价大涨5.32%报0.990港元
自选股智能写手 · 04-10
德琪医药-B盘中异动 下午盘股价大涨5.32%报0.990港元
德琪医药-B盘中异动 股价大涨8.70%报1.000港元
自选股智能写手 · 04-09
德琪医药-B盘中异动 股价大涨8.70%报1.000港元
德琪医药-B盘中异动 下午盘大幅上涨5.62%
自选股智能写手 · 04-08
德琪医药-B盘中异动 下午盘大幅上涨5.62%
德琪医药-B盘中异动 股价大跌5.21%报0.910港元
自选股智能写手 · 04-03
德琪医药-B盘中异动 股价大跌5.21%报0.910港元
德琪医药-B(06996)股价下跌5.208%,现价港币$0.91
阿斯达克财经 · 04-03
德琪医药-B(06996)股价下跌5.208%,现价港币$0.91
德琪医药-B(06996)股价下跌5%,现价港币$0.95
阿斯达克财经 · 04-02
德琪医药-B(06996)股价下跌5%,现价港币$0.95
从一份跑出"创新加速度"的年报,来看德琪医药-B(6996.HK)的价值提升路径
权证网 · 03-25
从一份跑出"创新加速度"的年报,来看德琪医药-B(6996.HK)的价值提升路径
德琪医药-B盘中异动 早盘股价大跌5.64%报1.020港元
自选股智能写手 · 03-25
德琪医药-B盘中异动 早盘股价大跌5.64%报1.020港元
德琪医药-B(06996):创新研发与全球化布局助力估值反弹,现金及银行结余达11.88亿元
和讯网 · 03-25
德琪医药-B(06996):创新研发与全球化布局助力估值反弹,现金及银行结余达11.88亿元
研发创新与全球化布局两翼齐飞,德琪医药-B(06996)按下估值反弹加速键
智通财经 · 03-25
研发创新与全球化布局两翼齐飞,德琪医药-B(06996)按下估值反弹加速键
《公司业绩》德琪医药-B(06996.HK)全年亏损收窄至5.81亿人币
阿斯达克财经 · 03-22
《公司业绩》德琪医药-B(06996.HK)全年亏损收窄至5.81亿人币
德琪医药-B(06996)发布年度业绩 毛利5501.2万元 管线资产取得稳步进展
智通财经 · 03-22
德琪医药-B(06996)发布年度业绩 毛利5501.2万元 管线资产取得稳步进展
德琪医药-B盘中异动 股价大涨5.26%
自选股智能写手 · 03-15
德琪医药-B盘中异动 股价大涨5.26%
德琪医药-B盘中异动 急速拉升9.43%
自选股智能写手 · 03-14
德琪医药-B盘中异动 急速拉升9.43%
德琪医药-B03月13日主力资金流出17万元 连续3日减仓
自选股智能写手 · 03-13
德琪医药-B03月13日主力资金流出17万元 连续3日减仓
德琪医药-B03月06日主力资金流出9万元 连续3日减仓
自选股智能写手 · 03-06
德琪医药-B03月06日主力资金流出9万元 连续3日减仓
德琪医药-B股价飙升17.17% 市值涨1.24亿港元
自选股智能写手 · 03-06
德琪医药-B股价飙升17.17% 市值涨1.24亿港元
暂无数据
公司概况
公司名称:
德琪医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。
发行价格:
--
{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":0.86,"timestamp":1713427695035,"preClose":0.89,"halted":0,"volume":182000,"delay":0,"floatShares":674888744,"shares":674888744,"eps":-1.0197614,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.03,"latestTime":"04-18 16:08:15","open":0.88,"high":0.9,"low":0.84,"amount":160645,"amplitude":0.067416,"askPrice":0.88,"askSize":500,"bidPrice":0.86,"bidSize":30500,"shortable":0,"etf":0,"ttmEps":-1.0197614851996866,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713490200000},"adr":0,"listingDate":1605801600000,"adjPreClose":0.89,"openAndCloseTimeList":[[1713403800000,1713412800000],[1713416400000,1713427200000]],"volumeRatio":0.775871,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996/tweets","defaultTab":"tweets","newsList":[{"id":"2428330144","title":"德琪医药-B盘中异动 早盘快速下跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428330144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428330144?lang=zh_cn&edition=full","pubTime":"2024-04-17 10:20","pubTimestamp":1713320438,"startTime":"0","endTime":"0","summary":"2024年04月17日早盘10时20分,德琪医药-B股票出现异动,股价急速下跌5.49%。德琪医药-B股票所在的药品行业中,整体涨幅为0.04%。其相关个股中,君圣泰医药-B、三爱健康集团、兴科蓉医药涨幅较大,振幅较大的相关个股有君圣泰医药-B、三爱健康集团、兴科蓉医药,振幅分别为25.17%、13.79%、6.12%。德琪医药-B公司简介:德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171020387a534e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171020387a534e7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428330263","title":"德琪医药-B(06996)股价显著下跌10.989%,现价港币$0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2428330263","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428330263?lang=zh_cn&edition=full","pubTime":"2024-04-17 10:20","pubTimestamp":1713320400,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药-B(06996) 股价在上午10:20比前收市价显著下跌10.989%,现股价为港币$0.81。至目前为止,今日最高价为$0.92,而最低价为$0.81。总成交量为13万股,总成交金额为港币$11.595万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240417518/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426718372","title":"德琪医药-B盘中异动 大幅跳水5.15%报0.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426718372","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426718372?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:11","pubTimestamp":1712905865,"startTime":"0","endTime":"0","summary":"2024年04月12日下午盘15时11分,德琪医药-B股票出现波动,股价快速下挫5.15%。截至发稿,该股报0.920港元/股,成交量59.25万股,换手率0.09%,振幅8.25%。资金方面,该股资金流入15.8055万港元,流出24.4845万港元。德琪医药-B股票所在的药品行业中,整体跌幅为0.08%。其相关个股中,天大药业、康臣药业、和黄医药涨幅较大,振幅较大的相关个股有精优药业、君圣泰医药-B、三爱健康集团,振幅分别为13.33%、11.76%、10.34%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121511057a525490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121511057a525490&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426482287","title":"德琪医药-B盘中异动 下午盘股价大涨5.32%报0.990港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426482287","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426482287?lang=zh_cn&edition=full","pubTime":"2024-04-10 13:02","pubTimestamp":1712725378,"startTime":"0","endTime":"0","summary":"2024年04月10日下午盘13时02分,德琪医药-B股票出现异动,股价急速拉升5.32%。截至发稿,该股报0.990港元/股,成交量6.7万股,换手率0.01%,振幅5.32%。资金方面,该股资金流入5.5715万港元,流出1895港元。德琪医药-B股票所在的药品行业中,整体跌幅为0.07%。其相关个股中,四环医药、德琪医药-B、东阳光长江药业涨幅较大,振幅较大的相关个股有三爱健康集团、中生联合、四环医药,振幅分别为17.65%、14.04%、9.62%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041013025887e7f1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041013025887e7f1e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426062183","title":"德琪医药-B盘中异动 股价大涨8.70%报1.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426062183","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426062183?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:51","pubTimestamp":1712631118,"startTime":"0","endTime":"0","summary":"2024年04月09日早盘10时51分,德琪医药-B股票出现异动,股价大幅拉升8.70%。截至发稿,该股报1.000港元/股,成交量9.05万股,换手率0.01%,振幅7.61%。资金方面,该股资金流入4.4505万港元,流出3.8175万港元。德琪医药-B股票所在的药品行业中,整体涨幅为0.08%。其相关个股中,德琪医药-B、和黄医药、开拓药业-B涨幅较大,振幅较大的相关个股有联康生物科技集团、长江生命科技、德琪医药-B,振幅分别为11.36%、7.79%、7.61%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091051587a51858f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091051587a51858f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425937796","title":"德琪医药-B盘中异动 下午盘大幅上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425937796","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425937796?lang=zh_cn&edition=full","pubTime":"2024-04-08 15:03","pubTimestamp":1712559831,"startTime":"0","endTime":"0","summary":"2024年04月08日下午盘15时03分,德琪医药-B股票出现异动,股价急速拉升5.62%。德琪医药-B股票所在的药品行业中,整体涨幅为0.23%。其相关个股中,长江生命科技、中国医疗集团、联康生物科技集团涨幅较大,振幅较大的相关个股有长江生命科技、中生联合、三爱健康集团,振幅分别为25.00%、14.29%、13.89%。德琪医药-B公司简介:德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040815035187e7e7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040815035187e7e7eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424867139","title":"德琪医药-B盘中异动 股价大跌5.21%报0.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424867139","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424867139?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:59","pubTimestamp":1712131154,"startTime":"0","endTime":"0","summary":"2024年04月03日临近收盘15时59分,德琪医药-B股票出现异动,股价大幅下挫5.21%。截至发稿,该股报0.910港元/股,成交量17.25万股,换手率0.03%,振幅6.25%。德琪医药-B股票所在的药品行业中,整体跌幅为0.13%。其相关个股中,联康生物科技集团、凯莱英、泰凌医药涨幅较大,振幅较大的相关个股有三爱健康集团、泰凌医药、前海健康,振幅分别为17.50%、13.64%、13.16%。德琪医药-B,一家拥有全球化自主研发、商业能力的生物制药企业,近日发布了2023年业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031559147a50e4b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031559147a50e4b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424041867","title":"德琪医药-B(06996)股价下跌5.208%,现价港币$0.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2424041867","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424041867?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:59","pubTimestamp":1712131140,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药-B(06996) 股价在下午03:59比前收市价下跌5.208%,现股价为港币$0.91。至目前为止,今日最高价为$0.97,而最低价为$0.91。总成交量为17.25万股,总成交金额为港币$16.188万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404031606/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424674039","title":"德琪医药-B(06996)股价下跌5%,现价港币$0.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2424674039","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424674039?lang=zh_cn&edition=full","pubTime":"2024-04-02 11:14","pubTimestamp":1712027640,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药-B(06996) 股价在上午11:14比前收市价下跌5%,现股价为港币$0.95。至目前为止,今日最高价为$1.0,而最低价为$0.95。总成交量为12.4万股,总成交金额为港币$12.126万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404022178/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422250713","title":"从一份跑出\"创新加速度\"的年报,来看德琪医药-B(6996.HK)的价值提升路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2422250713","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2422250713?lang=zh_cn&edition=full","pubTime":"2024-03-25 11:03","pubTimestamp":1711335786,"startTime":"0","endTime":"0","summary":"同时,德琪医药也正快速推进其他临床候选药物的研发进展。同时,希维奥成功纳入2023年国家医保药品目录。据最新财报数据显示,德琪医药2023全年实现收入6730.5万元,研发开支约4.06亿元,现金及银行结余约为11.88亿元,财务水平健康稳健。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251103108b5f4276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251103108b5f4276&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422671534","title":"德琪医药-B盘中异动 早盘股价大跌5.64%报1.020港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422671534","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422671534?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:58","pubTimestamp":1711335522,"startTime":"0","endTime":"0","summary":"2024年03月25日早盘10时58分,德琪医药-B股票出现波动,股价快速下挫5.64%。截至发稿,该股报1.020港元/股,成交量19.8万股,换手率0.03%,振幅3.70%。德琪医药-B股票所在的药品行业中,整体涨幅为0.26%。该信息摘要如下:德琪医药-B发布截至2023年12月31日止年度年度业绩,该集团期内取得收入6730.5万元;毛利5501.2万元;研发成本4.06亿元。截至2023年12月31日及2022年12月31日止年度,集团按非国际财务报告准则计量的经调整研发成本分别约为3.74亿元及人民币4.61亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032510584387e7b4e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032510584387e7b4e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422534946","title":"德琪医药-B(06996):创新研发与全球化布局助力估值反弹,现金及银行结余达11.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422534946","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2422534946?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:08","pubTimestamp":1711332519,"startTime":"0","endTime":"0","summary":"德琪医药-B凭借创新研发与全球化布局,迎来估值反弹的关键时期。随着国内生物医药产业政策的不断优化,德琪医药的创新研发战略得到了政策的有力支持。德琪医药在临床阶段的研发管线中,也布局了多个高潜力的创新靶点。2023年,德琪医药现金及银行结余达11.88亿元,为公司稳定估值和企业发展提供了坚实的基础。随着公司创新研发管线产品的陆续落地,德琪医药的内在价值有望得到进一步释放,成为公司股价和估值反弹的重要催化剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032510414987b102e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032510414987b102e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422582757","title":"研发创新与全球化布局两翼齐飞,德琪医药-B(06996)按下估值反弹加速键","url":"https://stock-news.laohu8.com/highlight/detail?id=2422582757","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422582757?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:10","pubTimestamp":1711329000,"startTime":"0","endTime":"0","summary":"而通过打造具有前瞻性、差异化的研发战略和丰富管线储备,持续构造国际化“同类首创”和“同类最优”竞争优势,德琪医药-B已然走在创新药趋势发展的最前沿,内在价值逐步得到释放。在当前全球热门的ADC赛道,德琪医药同样颇有建树。在双方合作下,希维奥在国内医院覆盖和市场渗透方面有望进一步加速。值得一提的是,去年12月14日,德琪医药正式宣布希维奥获纳入最新的国家医保目录名单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091198.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421698268","title":"《公司业绩》德琪医药-B(06996.HK)全年亏损收窄至5.81亿人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2421698268","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2421698268?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:49","pubTimestamp":1711097340,"startTime":"0","endTime":"0","summary":"德琪医药-B(06996.HK) 公布截至去年12月底止全年业绩,营业额6,730.5万元人民币(下同),按年跌58%。亏损收窄至5.81亿元,上年同期蚀6.01亿元;每股亏损94分。不派息。(jl/da)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/25中期业绩无派息2023/03/28末期业绩无派息 2022/08/30中期业绩无派息 2022/03/18末期业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210304121501620_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210304121501620_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336092/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2421767866","title":"德琪医药-B(06996)发布年度业绩 毛利5501.2万元 管线资产取得稳步进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2421767866","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421767866?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:48","pubTimestamp":1711097284,"startTime":"0","endTime":"0","summary":"智通财经APP讯,德琪医药-B 发布截至2023年12月31日止年度年度业绩,该集团期内取得收入6730.5万元;毛利5501.2万元;研发成本4.06亿元。于2023年,集团的管线资产取得稳步进展,且已于印度尼西亚提交希维奥的NDA申请,用于治疗复发╱难治性多发性骨髓瘤及弥漫大B细胞淋巴瘤。截至2023年12月31日及2022年12月31日止年度,集团按非国际财务报告准则计量的经调整研发成本分别约为3.74亿元及人民币4.61亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1090476.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419967796","title":"德琪医药-B盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419967796","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419967796?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:53","pubTimestamp":1710467622,"startTime":"0","endTime":"0","summary":"2024年03月15日早盘09时53分,德琪医药-B股票出现波动,股价快速拉升5.26%。德琪医药-B股票所在的药品行业中,整体涨幅为0.13%。其相关个股中,德琪医药-B、和黄医药、联邦制药涨幅较大,振幅较大的相关个股有和黄医药、君圣泰医药-B、翰森制药,振幅分别为6.40%、6.00%、5.72%。德琪医药-B公司简介:德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315095342791aaa5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315095342791aaa5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419692774","title":"德琪医药-B盘中异动 急速拉升9.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419692774","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419692774?lang=zh_cn&edition=full","pubTime":"2024-03-14 09:34","pubTimestamp":1710380059,"startTime":"0","endTime":"0","summary":"2024年03月14日早盘09时34分,德琪医药-B股票出现波动,股价快速上涨9.43%。德琪医药-B股票所在的药品行业中,整体涨幅为0.56%。其相关个股中,德琪医药-B、翰森制药、中国生物制药涨幅较大,振幅较大的相关个股有德琪医药-B、翰森制药、和黄医药,振幅分别为10.38%、9.82%、9.17%。德琪医药-B公司简介:德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314093419791a44b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314093419791a44b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419257103","title":"德琪医药-B03月13日主力资金流出17万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2419257103","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419257103?lang=zh_cn&edition=full","pubTime":"2024-03-13 16:15","pubTimestamp":1710317742,"startTime":"0","endTime":"0","summary":"03月13日,德琪医药-B股价收平报1.06元,成交金额73万元,换手率0.10%,振幅2.83%,量比1.21。德琪医药-B今日主力资金净流出17万元,连续3日净流出,上一交易日主力净流出17万元,今日环比减少0.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为25.00%,平均跌幅为4.68%。该股近5个交易日下跌3.64%,主力资金累计净流出72万元;近20日主力资金累计净流出118万元,其中净流出天数为10日。该股主力净额占比0.02%,港股市场排名2473/2626。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313161604877b7110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313161604877b7110&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417847255","title":"德琪医药-B03月06日主力资金流出9万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2417847255","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417847255?lang=zh_cn&edition=full","pubTime":"2024-03-06 16:16","pubTimestamp":1709713010,"startTime":"0","endTime":"0","summary":"03月06日,德琪医药-B股价收平报1.10元,成交金额94万元,换手率0.13%,振幅18.18%,量比1.09。德琪医药-B今日主力资金净流出9万元,连续3日净流出,上一交易日主力净流出29万元,今日环比减少68.97%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为14.29%,平均跌幅为2.64%。该股近5个交易日下跌12.00%,主力资金累计净流出66万元;近20日主力资金累计净流出47万元,其中净流出天数为6日。该股主力净额占比0.01%,港股市场排名2510/2627。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403061617428b0cea61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403061617428b0cea61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417409647","title":"德琪医药-B股价飙升17.17% 市值涨1.24亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417409647","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417409647?lang=zh_cn&edition=full","pubTime":"2024-03-06 09:30","pubTimestamp":1709688659,"startTime":"0","endTime":"0","summary":"2024年03月06日早盘09时30分,德琪医药-B股票出现异动,股价急速拉升17.17%。德琪医药-B股票所在的药品行业中,整体涨幅为0.03%。其相关个股中,德琪医药-B、三爱健康集团、联康生物科技集团涨幅较大,振幅较大的相关个股有三爱健康集团、康龙化成、康臣药业,振幅分别为4.00%、2.96%、2.12%。德琪医药-B公司简介:德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060931007917ad6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060931007917ad6f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.1134},{"period":"1month","weight":-0.2389},{"period":"3month","weight":-0.3857},{"period":"6month","weight":-0.3175},{"period":"1year","weight":-0.7065},{"period":"ytd","weight":-0.57}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.154186},{"month":2,"riseRate":0,"avgChangeRate":-0.104806},{"month":3,"riseRate":0.25,"avgChangeRate":-0.090913},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063391},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.046809},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.018925},{"month":7,"riseRate":0,"avgChangeRate":-0.174385},{"month":8,"riseRate":0,"avgChangeRate":-0.170216},{"month":9,"riseRate":0,"avgChangeRate":-0.124762},{"month":10,"riseRate":0.333333,"avgChangeRate":0.083701},{"month":11,"riseRate":1,"avgChangeRate":0.218251},{"month":12,"riseRate":0.5,"avgChangeRate":0.044026}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}